Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Research — Salary and employee benefits by Year
Research — Salary and employee benefits ($M) ($M)
Vertex Pharmaceuticals Research — Salary and employee benefits: $204M in FY2025, down 3.2% from a year earlier.
Where the FY2025 figure comes from
“|| Salary and benefits | $ 203.9 | (3)% | $ 210.7 | 14% | $ 184.1”
Source: Form 10-K (vrtx-20251231.htm, filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K MD&A (Research Expenses Disaggregation Table).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Vertex Pharmaceuticals Research — Salary and employee benefits ($M), annual FY2013–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rd-res-salary
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.